T-DM1 (trastuzumab emtansine)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for T-DM1 (trastuzumab emtansine), covering 2021-09-22 to 2021-09-22. Get the full timeline:
Most recent: Clinical Trial Update: Neoadjuvant TDM1 With Lapatinib and Abraxane Compared With Trastuzumab Plus Pertuzumab With Paclitaxel [Phase 2]